Scytalidium infection associated with dyskeratosis congenita [17]

British Journal of Dermatology

Volumn 156, Issue 3, 2007, Pages 604-606

  Garg, J ^a   Tilak, R ^a   Gulati, A K ^a   Singh, S ^a   Prakash, P ^a   Garg, A ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; AMPHOTERICIN B; CASPOFUNGIN; CHLORAMPHENICOL; CICLOPIROXOLAMINE; CYCLOHEXIMIDE; FLUCONAZOLE; GRISEOFULVIN; ISOTRETINOIN; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; TERBINAFINE; VORICONAZOLE;

DYSKERATOSIS CONGENITA; HUMAN; LETTER; LEUKOPLAKIA; MICROSCOPY; NAIL DYSTROPHY; ONCHOCERCIASIS; PRIORITY JOURNAL; SKIN PIGMENTATION;

ADOLESCENT; DYSKERATOSIS CONGENITA; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; ONYCHOMYCOSIS; OPPORTUNISTIC INFECTIONS;

EID: 33846969508     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07702.x     Document Type: Letter

References (8)

1. Gentles JC, Evans EGV. Infections of the feet and nails with Hendersonula toruloidea. Sabouraudia 1970; 8:72-5.
2. Sigler L, Summerbell RC, Poole L et al. Invasive Nattrassia mangiferae infections: case report, literature review, and therapeutic and taxonomic appraisal. J Clin Microbiol 1997; 35:433-40.
3. Hay RJ, Moore MK. Clinical features of superficial fungal infections caused by Hendersonula toruloidea and Scytalidium hyalinum. Br J Dermatol 1984; 110:677-83.
4. Kraemer KH. Heritable diseases with increased sensitivity to cellular injury. In: Fitzpatrick's Dermatology in General Medicine (Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, eds), 5th edn, Vol. 2. New York: McGraw-Hill, 1999; 1858-9.
5. Bagby GC, Lipton JM, Sloand EM, Schiffer CA. Marrow failure. Hematology 2004; 1:318-36.
6. Goon ATJ, Seow CS. Three cases of Nattrassia mangiferae (Scytalidium dimidiatum) infection in Singapore. Int J Dermatol 2002; 41:53-5.
7. Clayton YM. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br J Dermatol 1994; 130 (Suppl. 43):7-8.
8. Lecha M, Effendy I, Chauvin MF et al. Treatment options - development of consensus guidelines. J Eur Acad Dermatol Venereol 2005; 19 (Suppl. 1):25-33.